Reduced transforming growth factor-β type II receptor (TGF-β RII) expression in adenocarcinoma of the lung

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 301-306

  Kim, Won Seog ^a   Park, Chaehwa ^a   Jung, Yoo Sun ^a   Kim, Hae Sung ^a   Han, Joungho ^a   Park, Chan H ^a   Kim, Kwhanmien ^a   Kim, Jhingook ^a   Shim, Young Mog ^a   Park, Keunchil ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Non small cell lung cancer; TGF ; TGF type II receptor

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ADENOCARCINOMA; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032897720     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Brattain MG, Markowitz SD, Willson JKV: The type II transforming growth factor-receptor as a tumor-suppressor gene. Curr Opin Oncol 8: 49-53, 1996.
2. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Robberts AB, Sporn MB: Genetic changes in the trasforming growth factor (TGF-ß) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGH-ß. Proc Natl Acad Sci USA 91: 8772-8776, 1994.
3. Chang J, Park K, Bang Y-J. Kim WS, Kim D, Kim S-J: Expression of trasforming growth factor type II receptor reduces tumorigenecity in human gastric cancer cells Cancer Res 57: 2856-2859, 1997.
4. Lazzereschi D, Ranieri A, Mincione G, Taccogna S, Nardi F, Colletta G: Human malignant thyroid tumors displayed reduced levels of transforming growth factor receptor type II messenger RNA and protein. Cancer Res 57: 2071-2076, 1997.
5. Damstrup L, Rygaard K, Spang-Thomsen M, Poulsen HS: Expression of transforming growth factor (TGF) receptors and expression of TGF 1, TGF 2 and TGF 3 in human small lung cell lung cancer cell lines. Br J Cancer 67, 1015-1021, 1993.
6. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelcin MG, Miyazono K, Nemeth JA, Kozlowski JM, Lee C: Loss of expression of trasforming growth factor type I and type II receptors correlates with tumor grade in human prostate cancer tissue. Clin Cancer Res 2: 1255-1261, 1996.
7. Vincent F, Nagashima M, Takenoshita S, Khan MA, Gemma A, Hagiwara K, Bennett WP: Mutation analysis of the transforming growth factor-type II receptor in human cell lines resistant to growth inhibition by transforming growth factor. Oncogene 15: 117-122, 1997.
8. Norgaard P, Spang-Thomsen M, Poulsen HS: Expression and autoregulation of transforming growth factor receptor mRNA in small-cell lung cancer cell lines. Br J Cancer 73: 1037-1043, 1996.
9. Kim S-J, Romeo D, Yoo YD, Park K: Trasforming growth factor-ß: Expression in normal and pathological conditions. Horm Res 42: 5-8, 1994.
10. Lu S-L, Zhang W-C, Akiyama Y, Nomizu T, Yuasa Y: Genomic structure of the trasforming growth factor type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res 56: 4595-4598, 1996.
11. Koli KM, Arteaga CL: Predominant cytosolic localization of type II transforming growth factor receptor in human breast carcinoma cells. Cancer Res 57: 970-977, 1997.
12. Wang D, Song H, Evans J, Lang JC, Schuller DE, Weghorst CM: Mutation and downregulation of the transforming growth factor type II receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis 11: 2285-2290, 1997.
13. Dijke P, Miyazono K, Heldin C-H: Signaling via hetero-oligomeric complexs of type I and type II serine/threonine kinase receptors. Curr Opin Oncol 8: 139-145, 1996.
14. Myeroff LL, Parsons R, Kim S-J, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, Bang Y-J, Lee HY, Park J-G, Lynch HT, Roberts AB, Vogelstein B, Markowitz SD: A transforming growth factor receptor type II gene mutation common in colon and gastric hut rare in endometrial cancers with microsatellite instability. Cancer Res 55: 5545-5547, 1995.
15. Kiss A, Wang N-J, Xie J-P: Thorgeirsson. Analysis of transforming growth factor (TGF)-α/Epidermal growth factor receptor, hepatocyte growth factor/c-met, TGF-ß receptor type II. and p53 expression in human hepatocellular carcinomas. Clin Cancer Res 3: 1059-1066, 1997.
16. Ravitz MJ, Wenner CE: Cyclin -dependent kinase regulation during G1 phase and cell cycle regulation by TGF-ß. Advances in Cancer Res 71: 165-207, 1997.
17. Warna JL, Attisano L, Wieser R, Ventura F, Massague J: Mecanism of activation of lhe TGF-ß receptor. Nature 370: 341-346, 1994.
18. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L-P, Bapat B, Gallinger S, Andrulis IL, Thomson GH, Wrana JL, Attisano L: MADR 2 maps to 18q21 and encodes a TGF-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552, 1996.
19. Hata A, Lagna G, Hemmati - Brivanulou A, Massague J: In Abstracts of Keystone Symposium on Growth Control, p.29. Keystone, CO.
20. Maesawa C, Tamura G, Nishizuka S, Iwaya T, Ogasawara S, Ishida K, Sakata K, Sato N, Ikeda K, Kimura Y, Saito K, Satodate R: MAD-related genes on 18q21.1, S mad 2 and S mad 4, are altered infrequently in esophageal squamous cell carcinoma. Jpn J Cancer Res 88: 340-343, 1997.
21. Grau AM, Zhang L, Wang W, Ruan S, Evans DB, Evans DB, Abbruzzese JL, Zhang W, Chiao PL: Induction of p21 waf 1 expression and growth inhibition by transforming growth factor-involve the tumor suppressor gene DPC 4 in human pancreatic adenocarcinoma cells. Cancer Res 57: 3929-3934, 1997.
22. Massague J: TGF signaling: receptor, Transducers, and Mad proteins. Cell 85: 947-950, 1996.
23. Minna JD, Sekido Y, Fong KM, Gazdar AF: Molecular biology of lung cancer. In: Cancer (DeVita VT, Hellman S and Rosenberg SA, eds). New York, Lippincott-Raven Publ Corp, 1997, pp849-858.
24. Slebos R, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer C, Wagenaar SS, Vanderschueren R, Zandwijk NV, Mooi WJ, Bos JL, Rodenhuis S: K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 9: 561-565, 1990.
25. Rodenhuis S, van de Weltering ML, Mooi WJ, Evers SG, van Zandwijk N, Bos JL: a possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med. 317: 929-935, 1987.